申请人:Bhamidipati Somasekhar
公开号:US20130018041A1
公开(公告)日:2013-01-17
This invention is directed to compounds of formula (I):
where
n, m, Y, R
1
, R
2
, R
3
, R
4
and R
5
are disclosed herein, as isolated stereoisomers or mixtures thereof, or pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising the compounds of formula (I); and methods of using the compounds and the pharmaceutical compositions in treating diseases or conditions associated with JAK2 activity.
本发明涉及公式(I)的化合物:其中,n,m,Y,R1,R2,R3,R4和R5在此披露,作为隔离的立体异构体或混合物,或其药学上可接受的盐;包括公式(I)化合物的药物组合物;以及使用该化合物和药物组合物治疗与JAK2活性相关的疾病或情况的方法。